Personalized neurological fingerprint could increase effectiveness of Alzheimer’s treatment

Written by Natalie Morton, Future Science Group

Researchers from the Montreal Neurological Institute and Hospital of McGill University (Montreal, Canada) and the Ludmer Centre for Neuroinformatics and Mental Health (Montreal, Canada) have developed a personalized Therapeutic Intervention Fingerprint (pTIF), which is able to determine the potential effectiveness of targeting specific factors, such as brain amyloid, tau deposition and inflammation, within an individual patient. The use of personalized medicine within neurology is a long-standing aim for researchers and medical professionals alike and this is the first study to be able to draw an association between brain characteristics, gene expression and therapeutic response. Allowing treatments to be determined by...

To view this content, please register now for access

It's completely free